Android app Apple app link

AD/PD 2025: Roche's Brainshuttle technology promises next generation of amyloid beta mAbs

By Yahoo! Finance   |   3 weeks ago
AD/PD 2025: Roche's Brainshuttle technology promises next generation of amyloid beta mAbs

Roche presented promising data on trontinemab, a novel anti-amyloid monoclonal antibody using Brainshuttle technology for AD treatment at AD/PD 2025 Conference.

Read More

Did you find this insightful?

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

To become a member, please download and purchase membership through our app.